𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of human growth hormone and calcium phosphate by dynamic compaction:In vitro biocompatibility and bioactivity

✍ Scribed by Guicheux, J. ;Heymann, D. ;Tr�cant, M. ;Gautier, H. ;Faivre, A. ;Daculsi, G.

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
493 KB
Volume
36
Category
Article
ISSN
0021-9304

No coin nor oath required. For personal study only.

✦ Synopsis

The association of therapeutic agents with biomaterials has been achieved through various techniques, such as coating of the ceramic block surface or drug incorporation into ceramics. The dynamic compaction method recently was developed to consolidate drug-loaded calcium phosphate powder without a sintering step. In the present work, human recombinant growth hormone was loaded on biphasic calcium phosphate powder and consolidated by a specific process of cold sintering (dynamic compaction). Analyses of the biocompatibility of compacted pellets (mouse L929 fibroblastic cell culture) and the bioactivity of the drugs released by them (growth hormone bioassay) were performed. This report demonstrates the biocompatibility of the compacts prepared by dynamic compaction. L929 cell proliferation was maintained and the capacity to secrete fibronectin was conserved in the presence of compacted materials. Comparison of released growth hormone integrity, revealed by radioimmunoassay and eluted stain bioassay, has shown that the biological activity of growth hormone was totally preserved after dynamic compaction. However, 35% of loaded growth hormone was not released in our experimental conditions, probably because of the inaccessibility of growth hormone within the granulated compacts. Dynamic compaction shows good potential for the production of biomaterials capable of releasing therapeutic agents in situ.

📜 SIMILAR VOLUMES

Growth hormone stimulates the degradatio
Growth hormone stimulates the degradation of calcium phosphate biomaterial by human monocytes macrophagesin vitro
✍ Guicheux, J�r�me ;Kimakhe, Sa�d ;Heymann, Dominique ;Pilet, Paul ;Daculsi, Guy 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

This study investigated the effects of human growth hormone (hGH) on the monocyte/macrophage lineage, the first cell population involved in degradation of calcium phosphate ceramic after in vivo implantation. Monocytes isolated from human blood were cultured on biphasic calcium pellets (200 mg) for

Inhibition of proliferation in human MNN
Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone : Effects on insulin-like growth factor II
✍ Ryszard Braczkowski; Andrew V. Schally; Artur Plonowski; Jozsef L. Varga; Kate G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 2 views

## Abstract ## BACKGROUND Antagonists of growth hormone‐releasing hormone (GH‐RH) can inhibit the proliferation of various tumors either indirectly through the suppression of the pituitary growth hormone/hepatic insulin‐like growth factor I (__IGF‐I__) axis and the lowering of serum __IGF‐I__ conc

INTERLEUKIN-6-INDUCED PRODUCTION OF TYPE
INTERLEUKIN-6-INDUCED PRODUCTION OF TYPE II ACUTE PHASE PROTEINS AND EXPRESSION OF junB GENE ARE DOWNREGULATED BY HUMAN RECOMBINANT GROWTH HORMONE IN VITRO
✍ Beata Derfalvi; Peter Igaz; Kristof A Fulop; Csaba Szalai; Andras Falus 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB

## Abstract Growth hormone (GH), given therapeutically in many human diseases, is able to modulate the maturation and function of many cells of immune system. The present study demonstrates the effect of human recombinant GH on the production of acute phase proteins (APP) as well as on the gene exp